Liao M, Hao Y, Luo C, Chen C, Feng P, Yang H
J Liq Biopsy. 2025; 6:100167.
PMID: 40027304
PMC: 11863939.
DOI: 10.1016/j.jlb.2024.100167.
von Arx C, Calderaio C, Calabrese A, Marciano B, Martinelli C, Lauro V
Front Oncol. 2025; 14:1447508.
PMID: 39749036
PMC: 11693720.
DOI: 10.3389/fonc.2024.1447508.
Zhang Y, Tian L
Heliyon. 2024; 10(20):e39148.
PMID: 39492906
PMC: 11530831.
DOI: 10.1016/j.heliyon.2024.e39148.
Xu L, Wu Q, Zhao K, Li X, Yao W
Oncol Lett. 2024; 28(5):531.
PMID: 39290961
PMC: 11406422.
DOI: 10.3892/ol.2024.14664.
Liao C, Wu Z, Lin C, Chen X, Zou Y, Zhao W
Smart Med. 2024; 2(1):e20220020.
PMID: 39188554
PMC: 11236013.
DOI: 10.1002/SMMD.20220020.
Liquid biopsy for early detection of lung cancer.
Bibikova M, Fan J
Chin Med J Pulm Crit Care Med. 2024; 1(4):200-206.
PMID: 39171286
PMC: 11332910.
DOI: 10.1016/j.pccm.2023.08.005.
Clinical Application of Different Liquid Biopsy Components in Hepatocellular Carcinoma.
Xu J, Zhao Y, Chen Z, Wei L
J Pers Med. 2024; 14(4).
PMID: 38673047
PMC: 11051574.
DOI: 10.3390/jpm14040420.
Presence of CD44v9-Expressing Cancer Stem Cells in Circulating Tumor Cells and Effects of Carcinoembryonic Antigen Levels on the Prognosis of Colorectal Cancer.
Sawai K, Goi T, Kimura Y, Koneri K
Cancers (Basel). 2024; 16(8).
PMID: 38672639
PMC: 11048819.
DOI: 10.3390/cancers16081556.
3D-Stacked Multistage Inertial Microfluidic Chip for High-Throughput Enrichment of Circulating Tumor Cells.
Xu X, Huang X, Sun J, Chen J, Wu G, Yao Y
Cyborg Bionic Syst. 2024; 2022:9829287.
PMID: 38645277
PMC: 11030111.
DOI: 10.34133/2022/9829287.
The Role of Circulating Tumor Cells as a Liquid Biopsy for Cancer: Advances, Biology, Technical Challenges, and Clinical Relevance.
Allen T
Cancers (Basel). 2024; 16(7).
PMID: 38611055
PMC: 11010957.
DOI: 10.3390/cancers16071377.
Single-Cell Proteomics by Barcoded Phage-Displayed Screening via an Integrated Microfluidic Chip.
Wang Y, Zhao J, Jiang Z, Ma Y, Zhang R
Methods Mol Biol. 2024; 2793:101-112.
PMID: 38526726
DOI: 10.1007/978-1-0716-3798-2_7.
Immune checkpoints HLA-E:CD94-NKG2A and HLA-C:KIR2DL1 complementarily shield circulating tumor cells from NK-mediated immune surveillance.
Liu X, Zuo F, Song J, Tang L, Wang X, Liu X
Cell Discov. 2024; 10(1):16.
PMID: 38336855
PMC: 10858264.
DOI: 10.1038/s41421-024-00646-3.
CTC together with Shh and Nrf2 are prospective diagnostic markers for HNSCC.
Rahman M, Hossain M, Islam S, Ahmed R, Majumder M, Dey S
BMC Mol Cell Biol. 2024; 25(1):4.
PMID: 38336617
PMC: 10858504.
DOI: 10.1186/s12860-024-00500-0.
A Comprehensive Review of the Potential Role of Liquid Biopsy as a Diagnostic, Prognostic, and Predictive Biomarker in Pancreatic Ductal Adenocarcinoma.
Stosic K, Azurmendi Senar O, Tarfouss J, Bouchart C, Navez J, Van Laethem J
Cells. 2024; 13(1).
PMID: 38201207
PMC: 10778087.
DOI: 10.3390/cells13010003.
Solute-particle separation in microfluidics enhanced by symmetrical convection.
Yao Y, Lin Y, Wu Z, Li Z, He X, Wu Y
RSC Adv. 2024; 14(3):1729-1740.
PMID: 38192326
PMC: 10772704.
DOI: 10.1039/d3ra07285a.
Circulating tumor cells participate in the formation of microvascular invasion and impact on clinical outcomes in hepatocellular carcinoma.
Sun B, Ji W, Wang W, Chen L, Ma J, Tang E
Front Genet. 2023; 14:1265866.
PMID: 38028589
PMC: 10652898.
DOI: 10.3389/fgene.2023.1265866.
A Novel Electrokinetic-Based Technique for the Isolation of Circulating Tumor Cells.
Manshadi M, Saadat M, Mohammadi M, Nezhad A
Micromachines (Basel). 2023; 14(11).
PMID: 38004919
PMC: 10672846.
DOI: 10.3390/mi14112062.
The Evolution of Affordable Technologies in Liquid Biopsy Diagnostics: The Key to Clinical Implementation.
Alexandrou G, Mantikas K, Allsopp R, Yapeter C, Jahin M, Melnick T
Cancers (Basel). 2023; 15(22).
PMID: 38001698
PMC: 10670715.
DOI: 10.3390/cancers15225434.
A Radiomics Approach to Identify Immunologically Active Tumor in Patients with Head and Neck Squamous Cell Carcinomas.
Nguyen T, Bertolus C, Giraud P, Burgun A, Saintigny P, Bibault J
Cancers (Basel). 2023; 15(22).
PMID: 38001629
PMC: 10670096.
DOI: 10.3390/cancers15225369.
Hydrogel-based technologies in liquid biopsy for the detection of circulating clinical markers: challenges and prospects.
Kim Y, Min J
Anal Bioanal Chem. 2023; 416(9):2065-2078.
PMID: 37963993
DOI: 10.1007/s00216-023-05025-7.